메뉴 건너뛰기
Lancet Oncology
Volumn 6, Issue 5, 2005, Pages 256-257
The end for genital human papillomavirus infections?
Author keywords

[No Author keywords available]
Indexed keywords

CAPSID PROTEIN; HUMAN PAPILLOMAVIRUS VIRUS VACCINE; NEUTRALIZING ANTIBODY; PLACEBO; PROTEIN L1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VACCINE;
EID: 17844398718     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70141-8     Document Type: Letter
Times cited : (9)
References (8)
  • 1
    • 0142062150 scopus 로고    scopus 로고
    • Human papillomavirus and cervical cancer: Burden and assessment of causality
    • Bosch FX S de Sanjose Human papillomavirus and cervical cancer: Burden and assessment of causality J Natl Cancer Inst Monogr 31 2003 3-13
    • (2003) J. Natl. Cancer Inst. Monogr. , vol.31 , pp. 3-13
    • Bosch, F.X.1    de Sanjose, S.2
  • 2
    • 7044262106 scopus 로고    scopus 로고
    • Human papillomavirus (HPV) vaccines: Prospects for eradicating cervical cancer
    • Stanley MA Human papillomavirus (HPV) vaccines: Prospects for eradicating cervical cancer J Fam Plann Reprod Health Care 30 2004 213-215
    • (2004) J. Fam. Plann. Reprod Health Care , vol.30 , pp. 213-215
    • Stanley, M.A.1
  • 3
    • 0142030165 scopus 로고    scopus 로고
    • Chapter 16: Prophylactic human papillomavirus vaccines
    • Lowy DR Frazer IH Chapter 16: Prophylactic human papillomavirus vaccines J Natl Cancer Inst Monogr 31 2003 111-116
    • (2003) J. Natl. Cancer Inst. Monogr. , vol.31 , pp. 111-116
    • Lowy, D.R.1    Frazer, I.H.2
  • 4
    • 0037153042 scopus 로고    scopus 로고
    • A controlled trial of a human papillomavirus type 16 vaccine
    • Koutsky LA Ault KA Wheeler CM et al. A controlled trial of a human papillomavirus type 16 vaccine N Engl J Med 347 2002 1645-1651
    • (2002) N. Engl. J. Med. , vol.347 , pp. 1645-1651
    • Koutsky, L.A.1    Ault, K.A.2    Wheeler, C.M.3
  • 5
    • 8444249386 scopus 로고    scopus 로고
    • Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial
    • Harper DM Franco EL Wheeler CM et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial Lancet 364 2004 1757-1765
    • (2004) Lancet , vol.364 , pp. 1757-1765
    • Harper, D.M.1    Franco, E.L.2    Wheeler, C.M.3
  • 6
    • 20944448032 scopus 로고    scopus 로고
    • Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women a randomised double-blind placebo-controlled multicentre phase II efficacy trial
    • Villa LL Costa RLR Petta CA et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncol 6 2005 271-278
    • (2005) Lancet Oncol. , vol.6 , pp. 271-278
    • Villa, L.L.1    Costa, R.L.R.2    Petta, C.A.3
  • 7
    • 0029773651 scopus 로고    scopus 로고
    • Antibodies to human papillomavirus type 11 particles in sera of patients with genital warts and in control groups
    • Eisemann C Fisher SG Gross G et al. Antibodies to human papillomavirus type 11 particles in sera of patients with genital warts and in control groups J Gen Virol 77 1996 1799-1803
    • (1996) J. Gen. Virol. , vol.77 , pp. 1799-1803
    • Eisemann, C.1    Fisher, S.G.2    Gross, G.3
  • 8
    • 0029033890 scopus 로고
    • Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts
    • Carter JJ Wipf GC Hagensee ME et al. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts J Infect Dis 172 1995 11-18
    • (1995) J. Infect. Dis. , vol.172 , pp. 11-18
    • Carter, J.J.1    Wipf, G.C.2    Hagensee, M.E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.